Well, congrats on the funding round. You guys are putting up some big numbers. Look, I know that you closed out the year having doubled your bookings and you closed out the year in 2025 cash flow positive. I'm trying to get a sense for the top line here. What are you guys doing in terms of revenue right now?
Well, thank you. It's been an extraordinary 2025, really the last 12 months for the business. We exited 2025 with 103% bookings growth, 1.1 billion run on bookings, about an 800 million revenue run rate. Whoop is mostly a recurring revenue business, so our bookings tends to be out ahead of our revenue, and it's yeah, it's a really exciting time for the company.
So, revenue of 800 million. So, is 800 million, did that double as well year-over-year compared to this time last year?
From a run rate standpoint, yes, close to it.
Okay. And tell me, so you guys are pushing internationally quite a bit. What percent of that revenue, that 800 million, is coming from outside of North America now?
Our business today is about 40% US, 60% rest of the world. You know, we started about 3 years ago really focusing on international expansion, and so we went from mostly being a US business to being in 60 markets around the world. We've got members now in over 200 countries, and it still feels like early days. You know, Whoop is translated in about five or six languages, so we haven't done full translation. We've only really done full funnel marketing in, you know, some of these new markets, and as we look to the future, a lot of the capital that we've raised will be able to apply towards global expansion.
Well, it remains to be seen. We still have it on a timeline of about 2 years, and we've got a very strong balance sheet today, which is also, you know, critical. And the business operated 2025 cash flow positive, which is a big milestone for the company, especially at our scale. And so that just gives us, I think, a lot of control over our destiny, and in terms of how we think about being private versus public.
So, look, long-time subscribers of The Information may remember, and you don't have to go back too far, but 2 years ago I came down to Boston and we shared a workout together. We did ice baths together. You showed me the whole Whoop experience. That was in 2024, and at that point, I mean, we were talking about the next generation of what Whoop could look like, and you were talking a lot about health and specifically health features that you wanted to implement in the product. And since then, you have obviously integrated your health span features. You've got the ECG and the blood pressure insights, and so you've got a lot of health in the product now in addition to the fitness stuff that you've sort of built the foundation on. What I want to know is, what does the next generation of Whoop look like from here? I mean, where do you go now?
In the last 12 months, I think we've done a good job building out Whoop really as a health platform. As you know, our origins were in sports and performance, and you know, I started this company in 2012, so 14 years ago. And over the last 14 years, we've really evolved from sports and performance to, you know, general fitness to now a really broad-based consumer market with health very much so at the forefront. And we launched health span recently, which of course is our internal metric for being able to tell our members how old they are physiologically and based on their behavior versus, of course, their chronological age. And we've seen that become one of the most popular features now on Whoop. And I think you don't have to look much further than what we've done recently to anticipate what's to come. You know, we're going to be leaning into more medical clearances, more sensing capabilities, more products and services broadly within health. Our advanced labs capability, which is blood testing, we've just begun rolling out specialized panels, and very soon we're going to have that be an international offering along with being a US offering.
So, more medical clearance. I mean, what type of clearances are we talking about here?
Well, you can imagine a variety of different capabilities that really, you know, are able to alert our members when something's wrong. I think the FDA's done a good job recently distinguishing between wellness capabilities and medical capabilities, and this was an area that was important to us to gain clarity on. You know, so wellness, for example, is heart rate monitoring for exercise, sleep monitoring to understand recovery. On the flip side, you know, medical is heart rate monitoring to determine whether you have AFib. And so recently we got medical clearance to do ECG monitoring to detect AFib, and that's now a medically cleared product. You know, the sleep equivalent of that might be sleep apnea, and so on and so forth. So we see that there's a lot of, you know, really valuable medical applications for our technology. Increasingly we get messages from our members about not just how Whoop has improved their life, but even saved their life. And we want to be able to be more proactive in that alerting approach.
So, you know, I was kind of curious to get your take on some of the health trends that are sweeping through Silicon Valley right now. It's a little further away from what you guys are doing, but I mean, look, peptides are the thing that is really, you know, dominating the conversation. Again, not at all parallel to what you're doing, but it's a thing that is happening. It's in the conversation. I mean, what do you think of that trend?